Anders Edsjö

2.6k total citations
44 papers, 1.7k citations indexed

About

Anders Edsjö is a scholar working on Cancer Research, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Anders Edsjö has authored 44 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Cancer Research, 17 papers in Molecular Biology and 11 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Anders Edsjö's work include Cancer Genomics and Diagnostics (11 papers), MicroRNA in disease regulation (10 papers) and Neuroblastoma Research and Treatments (7 papers). Anders Edsjö is often cited by papers focused on Cancer Genomics and Diagnostics (11 papers), MicroRNA in disease regulation (10 papers) and Neuroblastoma Research and Treatments (7 papers). Anders Edsjö collaborates with scholars based in Sweden, United States and Belgium. Anders Edsjö's co-authors include Anders Bjartell, Yvonne Ceder, Zandra Hagman, Olivia Larne, Sven Påhlman, Hans Lilja, Benedikta S. Haflidadóttir, Christer Larsson, Sofia Winslow and Linda Holmquist Mengelbier and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Anders Edsjö

43 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anders Edsjö Sweden 23 1.1k 1.0k 465 308 172 44 1.7k
Wenyuan Zhao China 21 863 0.8× 589 0.6× 347 0.7× 271 0.9× 107 0.6× 80 1.4k
Timothy A. Chan United States 9 1.4k 1.3× 863 0.8× 302 0.6× 357 1.2× 90 0.5× 13 2.2k
Chirayu Goswami United States 25 1.1k 1.0× 572 0.6× 235 0.5× 443 1.4× 117 0.7× 44 1.8k
L. Magnus Bäcklund Sweden 20 848 0.8× 658 0.6× 558 1.2× 473 1.5× 403 2.3× 35 2.2k
Lucie Karayan‐Tapon France 23 794 0.7× 524 0.5× 331 0.7× 467 1.5× 72 0.4× 61 1.6k
Robert S. Seitz United States 21 875 0.8× 461 0.4× 396 0.9× 493 1.6× 102 0.6× 42 1.8k
Kenneth Aldape United States 13 1.2k 1.1× 686 0.7× 347 0.7× 557 1.8× 68 0.4× 32 1.9k
Yesim Gökmen‐Polar United States 26 1.1k 1.0× 416 0.4× 163 0.4× 430 1.4× 200 1.2× 92 1.7k
Siew‐Kee Low Japan 21 447 0.4× 486 0.5× 267 0.6× 408 1.3× 82 0.5× 46 1.3k
Carlota Rubio-Pérez Spain 13 1.0k 1.0× 830 0.8× 376 0.8× 451 1.5× 74 0.4× 17 1.9k

Countries citing papers authored by Anders Edsjö

Since Specialization
Citations

This map shows the geographic impact of Anders Edsjö's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anders Edsjö with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anders Edsjö more than expected).

Fields of papers citing papers by Anders Edsjö

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anders Edsjö. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anders Edsjö. The network helps show where Anders Edsjö may publish in the future.

Co-authorship network of co-authors of Anders Edsjö

This figure shows the co-authorship network connecting the top 25 collaborators of Anders Edsjö. A scholar is included among the top collaborators of Anders Edsjö based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anders Edsjö. Anders Edsjö is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Edsjö, Anders, Hege G. Russnes, Janne Lehtiö, et al.. (2024). High‐throughput molecular assays for inclusion in personalised oncology trials – State‐of‐the‐art and beyond. Journal of Internal Medicine. 295(6). 785–803. 5 indexed citations
2.
Edsjö, Anders, David Gisselsson, Johan Staaf, et al.. (2024). Current and emerging sequencing-based tools for precision cancer medicine. Molecular Aspects of Medicine. 96. 101250–101250. 4 indexed citations
3.
Gelderblom, Hans, Anders Edsjö, Ulrik Lassen, et al.. (2023). 1711P The DRUP-like clinical trials family: A distributed European trial network for equitable access to precision medicine. Annals of Oncology. 34. S933–S934. 1 indexed citations
4.
Edsjö, Anders, Birgit Geoerger, Frédérique Nowak, et al.. (2023). Precision cancer medicine: Concepts, current practice, and future developments. Journal of Internal Medicine. 294(4). 455–481. 31 indexed citations
5.
Edsjö, Anders, Anna Lindstrand, David Gisselsson, et al.. (2023). Building a precision medicine infrastructure at a national level: The Swedish experience. SHILAP Revista de lepidopterología. 1. e15–e15. 5 indexed citations
6.
7.
Voss, Gjendine, Anders Edsjö, Anders Bjartell, & Yvonne Ceder. (2021). Quantification of microRNA editing using two-tailed RT-qPCR for improved biomarker discovery. RNA. 27(11). 1412–1424. 11 indexed citations
8.
Odin, Elisabeth, Anders Edsjö, Göran Carlsson, et al.. (2017). Expression of folate pathway genes with putative impact on leucovorin metabolism and outcome of patients with advanced colorectal cancer. Annals of Oncology. 28. iii98–iii98. 2 indexed citations
9.
Winslow, Sofia, Kajsa Ericson Lindquist, Anders Edsjö, & Christer Larsson. (2016). The expression pattern of matrix-producing tumor stroma is of prognostic importance in breast cancer. BMC Cancer. 16(1). 841–841. 54 indexed citations
10.
Larne, Olivia, Zandra Hagman, Hans Lilja, et al.. (2015). miR-145 suppress the androgen receptor in prostate cancer cells and correlates to prostate cancer prognosis. Carcinogenesis. 36(8). 858–866. 57 indexed citations
11.
Cree, Ian A., Zandra C. Deans, Marjolijn J. L. Ligtenberg, et al.. (2014). Guidance for laboratories performing molecular pathology for cancer patients. Journal of Clinical Pathology. 67(11). 923–931. 154 indexed citations
12.
Haflidadóttir, Benedikta S., Olivia Larne, Myriam Martin, et al.. (2013). Upregulation of miR-96 Enhances Cellular Proliferation of Prostate Cancer Cells through FOXO1. PLoS ONE. 8(8). e72400–e72400. 77 indexed citations
13.
Lippolis, Giuseppe, et al.. (2013). Automatic registration of multi-modal microscopy images for integrative analysis of prostate tissue sections. BMC Cancer. 13(1). 408–408. 18 indexed citations
14.
Dijkstra, Jeroen R., Frank J.M. Opdam, Jerry Boonyaratanakornkit, et al.. (2012). Implementation of Formalin-Fixed, Paraffin-Embedded Cell Line Pellets as High-Quality Process Controls in Quality Assessment Programs for KRAS Mutation Analysis. Journal of Molecular Diagnostics. 14(3). 187–191. 10 indexed citations
15.
Larne, Olivia, Elena S. Martens‐Uzunova, Zandra Hagman, et al.. (2012). miQ—A novel microRNA based diagnostic and prognostic tool for prostate cancer. International Journal of Cancer. 132(12). 2867–2875. 72 indexed citations
16.
Östling, Päivi, Suvi‐Katri Leivonen, Anna Aakula, et al.. (2011). Systematic Analysis of MicroRNAs Targeting the Androgen Receptor in Prostate Cancer Cells. Cancer Research. 71(5). 1956–1967. 227 indexed citations
17.
Dahlman, Anna, Anders Edsjö, Christer Halldén, et al.. (2010). Effect of androgen deprivation therapy on the expression of prostate cancer biomarkers MSMB and MSMB-binding protein CRISP3. Prostate Cancer and Prostatic Diseases. 13(4). 369–375. 26 indexed citations
18.
Edsjö, Anders, Helén Nilsson, Jo Vandesompele, et al.. (2004). Neuroblastoma cells with overexpressed MYCN retain their capacity to undergo neuronal differentiation. Laboratory Investigation. 84(4). 406–417. 41 indexed citations
19.
Edsjö, Anders, Erik Lavenius, Helén Nilsson, et al.. (2003). Expression of trkB in Human Neuroblastoma in Relation to MYCN Expression and Retinoic Acid Treatment. Laboratory Investigation. 83(6). 813–823. 54 indexed citations
20.
Vandesompele, Jo, Anders Edsjö, Katleen De Preter, et al.. (2003). ID2 expression in neuroblastoma does not correlate to MYCN levels and lacks prognostic value. Oncogene. 22(3). 456–460. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wenyuan Zhao Breakdown of academic impact, for papers by Timothy A. Chan Breakdown of academic impact, for papers by Chirayu Goswami Breakdown of academic impact, for papers by L. Magnus Bäcklund Breakdown of academic impact, for papers by Lucie Karayan‐Tapon Breakdown of academic impact, for papers by Robert S. Seitz Breakdown of academic impact, for papers by Kenneth Aldape Breakdown of academic impact, for papers by Yesim Gökmen‐Polar Breakdown of academic impact, for papers by Siew‐Kee Low Breakdown of academic impact, for papers by Carlota Rubio-Pérez
Rankless by CCL
2026